A month has gone by since the last earnings report for VIVUS, Inc. VVUS. Shares have lost about 19.8% in that time frame, underperforming the market. Will the recent negative trend continue leading up to the stock's next earnings …
Boston, Massachusetts headquartered Vertex Pharmaceuticals Inc.'s stock finished Thursday's session 2.95% lower at $127.24 with a total trading volume of 1.37 million shares. Over the last month and the previous three months, the …
VIVUS Inc. VVUS reported a loss of 6 cents per share in the third quarter ... In fact, so far this year, VIVUS shares have underperformed the industry. The stock declined 43.4% during the period, while the industry witnessed a gain of 3.1%.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VVUS at https://www.zacks.com/ap/VVUS Keywords: Vivus, Earnings Report